Studies have shown that interference with FOXM1 in fibroblasts or the administration of FOXM1 inhibitors reduces the expression of bleomycin-induced pulmonary-fibrosis-associated factors [50,85]. This evidence concerns the gene FOXM1 and pulmonary fibrosis.